LH
Lantheus Holdings Inc
🇺🇸XNAS.LNTHUnited StatesHealthcare
$100.83USDup +0.10 (+0.1%)OpenDelayed5:38 PM
Price$100.83+0.10 (+0.1%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5165441032
- CUSIP
- 516544103
Company
- Employees
- 1,193
- Headquarters
- Bedford, United States
- Website
- https://www.lantheus.com
- CEO
- Ms. Mary Anne Heino
Market
- Shares outstanding
- 65.3M
- Market cap
- $6.58B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $6.58B
- EPS LTM
- $4.22calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 23.92calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.56B+2.35%up year on year
- Net income
- $275.31M+1.59%up year on year
- Gross margin
- 60.14%-5.65%down year on year
- Free cash flow
- $509.73M+8.26%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.